Beijing Tong Ren Tang Chinese Medicine Co Ltd
F:TQR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
F:TQR
|
HK |
|
GVS SpA
F:4YQ
|
IT |
|
K
|
Kyowa Kirin Co Ltd
DUS:KY4
|
JP |
|
Traffic Technologies Ltd
ASX:TTI
|
AU |
|
CML Microsystems Plc
F:92M
|
UK |
|
Fine Sinter Co Ltd
TSE:5994
|
JP |
|
A
|
Amiad Water Systems Ltd
TASE:AMD
|
IL |
|
E
|
Evergreen Corp
NASDAQ:EVGR
|
US |
|
A
|
Advertigo SA
WSE:AVE
|
PL |
|
F
|
Fiplasto SA
BCBA:FIPL
|
AR |
|
C
|
Canadian North Resources Inc
F:EO0
|
CA |
|
Sihayo Gold Ltd
ASX:SIH
|
AU |
|
T
|
Tiger Elec Co Ltd
KOSDAQ:219130
|
KR |
|
Nickel Rock Resources Inc
XTSX:NICL
|
CA |
|
Pacte Novation SA
PAR:MLPAC
|
FR |
|
Chakana Copper Corp
F:1ZX0
|
CA |
|
L
|
Linkgenesis Co Ltd
KOSDAQ:219420
|
KR |
|
Foxwell Power Co Ltd
TWSE:6994
|
TW |
|
Benson Hill Inc
NASDAQ:BHIL
|
US |
|
Nanomix Corp
OTC:NNMX
|
US |
|
C
|
Crescent Cotton Mills Ltd
KAR:CCM
|
PK |
|
A
|
Alta SA
WSE:AAT
|
PL |
|
Arden Partners PLC
LSE:ARDN
|
UK |
|
N
|
NanoFlex Power Corp
OTC:OPVS
|
US |
Wall St Price Targets
TQR Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for TQR is 1.45 EUR with a low forecast of 1.4 EUR and a high forecast of 1.52 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TQR's stock price target?
Price Target
1.45
EUR
According to Wall Street analysts, the average 1-year price target for TQR is 1.45 EUR with a low forecast of 1.4 EUR and a high forecast of 1.52 EUR.
What is the Revenue forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 1 year is 34%.
What is the Operating Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 23%.
What is the Pre-Tax Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 23%.
